company background image
PFE logo

Pfizer NYSE:PFE Stock Report

Last Price

US$28.97

Market Cap

US$163.9b

7D

-2.3%

1Y

-9.7%

Updated

26 Sep, 2024

Data

Company Financials +

PFE Stock Overview

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally.

PFE fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance0/6
Financial Health0/6
Dividends4/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

US$33.61
FV
13.8% undervalued intrinsic discount
5.23%
Revenue growth p.a.
2users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
4 days agoauthor updated this narrative

Pfizer Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pfizer
Historical stock prices
Current Share PriceUS$28.97
52 Week HighUS$34.11
52 Week LowUS$25.20
Beta0.62
11 Month Change0.52%
3 Month Change3.54%
1 Year Change-9.72%
33 Year Change-32.64%
5 Year Change-18.28%
Change since IPO6,293.39%

Recent News & Updates

There's Reason For Concern Over Pfizer Inc.'s (NYSE:PFE) Price

Sep 23
There's Reason For Concern Over Pfizer Inc.'s (NYSE:PFE) Price

Pfizer: Undervalued Healthcare Leader Poised For Further Recovery

Sep 23

Recent updates

There's Reason For Concern Over Pfizer Inc.'s (NYSE:PFE) Price

Sep 23
There's Reason For Concern Over Pfizer Inc.'s (NYSE:PFE) Price

Pfizer: Undervalued Healthcare Leader Poised For Further Recovery

Sep 23

Why Pfizer Investors Should Closely Monitor VAX-31

Sep 05

Pfizer: Look Beyond COVID-19 And The Patent Cliffs - Robust Long-Term Tailwinds

Aug 30

Pfizer: Performance Is Improving, But Secular Issues Persist (Rating Upgrade)

Aug 23

Pfizer: Growing Beyond Covid

Aug 13

Pfizer Stock: It May Be Just The Beginning Of A Solid Rally

Aug 01

Pfizer's Q2 Focus: Core Products And New Ventures

Jul 25

Shareholder Returns

PFEUS PharmaceuticalsUS Market
7D-2.3%-1.4%0.6%
1Y-9.7%22.2%32.1%

Return vs Industry: PFE underperformed the US Pharmaceuticals industry which returned 22.2% over the past year.

Return vs Market: PFE underperformed the US Market which returned 32.1% over the past year.

Price Volatility

Is PFE's price volatile compared to industry and market?
PFE volatility
PFE Average Weekly Movement2.8%
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.4%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: PFE has not had significant price volatility in the past 3 months.

Volatility Over Time: PFE's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
184988,000Albert Bourlawww.pfizer.com

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands.

Pfizer Inc. Fundamentals Summary

How do Pfizer's earnings and revenue compare to its market cap?
PFE fundamental statistics
Market capUS$163.94b
Earnings (TTM)-US$2.59b
Revenue (TTM)US$55.17b

3.0x

P/S Ratio

-63.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PFE income statement (TTM)
RevenueUS$55.17b
Cost of RevenueUS$21.98b
Gross ProfitUS$33.19b
Other ExpensesUS$35.78b
Earnings-US$2.59b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 29, 2024

Earnings per share (EPS)-0.46
Gross Margin60.16%
Net Profit Margin-4.70%
Debt/Equity Ratio79.4%

How did PFE perform over the long term?

See historical performance and comparison

Dividends

5.8%

Current Dividend Yield

-362%

Payout Ratio